Follow
Michael Berk
Michael Berk
Verified email at deakin.edu.au - Homepage
Title
Cited by
Cited by
Year
Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors
M Berk, F Kapczinski, AC Andreazza, OM Dean, F Giorlando, M Maes, ...
Neuroscience & biobehavioral reviews 35 (3), 804-817, 2011
11822011
Oxidative stress in psychiatric disorders: evidence base and therapeutic implications
F Ng, M Berk, O Dean, AI Bush
The the International Journal of Neuropsychopharmacology 11 (6), 851-876, 2008
11752008
So depression is an inflammatory disease, but where does the inflammation come from?
M Berk, LJ Williams, FN Jacka, A O’Neil, JA Pasco, S Moylan, NB Allen, ...
BMC medicine 11 (1), 1-16, 2013
11742013
Bipolar disorder
I Grande, M Berk, B Birmaher, E Vieta
The Lancet 387 (10027), 1561-1572, 2016
11672016
A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro) degenerative processes in that illness
M Maes, P Galecki, YS Chang, M Berk
Progress in Neuro-Psychopharmacology and Biological Psychiatry 35 (3), 676-692, 2011
11142011
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of†…
LN Yatham, SH Kennedy, SV Parikh, A Schaffer, S Beaulieu, M Alda, ...
Bipolar disorders 15 (1), 1-44, 2013
9842013
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar†…
LN Yatham, SH Kennedy, SV Parikh, A Schaffer, DJ Bond, BN Frey, ...
Bipolar disorders 20 (2), 97-170, 2018
9742018
Association of Western and traditional diets with depression and anxiety in women
FN Jacka, JA Pasco, A Mykletun, LJ Williams, AM Hodge, SL O'Reilly, ...
American journal of psychiatry 167 (3), 305-311, 2010
8722010
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of†…
LN Yatham, SH Kennedy, A Schaffer, SV Parikh, S Beaulieu, ...
Bipolar disorders 11 (3), 225-255, 2009
7702009
The chemistry and biological activities of N-acetylcysteine
Y Samuni, S Goldstein, OM Dean, M Berk
Biochimica et Biophysica Acta (BBA)-General Subjects 1830 (8), 4117-4129, 2013
7352013
Effect of aspirin on cardiovascular events and bleeding in the healthy elderly
JJ McNeil, R Wolfe, RL Woods, AM Tonkin, GA Donnan, MR Nelson, ...
New England Journal of Medicine 379 (16), 1509-1518, 2018
7032018
A randomised controlled trial of dietary improvement for adults with major depression (the ‘SMILES’trial)
FN Jacka, A O’Neil, R Opie, C Itsiopoulos, S Cotton, M Mohebbi, D Castle, ...
BMC medicine 15 (1), 1-13, 2017
6592017
The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders
I Pacchiarotti, DJ Bond, RJ Baldessarini, WA Nolen, H Grunze, RW Licht, ...
American Journal of Psychiatry 170 (11), 1249-1262, 2013
6572013
N-acetyl cysteine as a glutathione precursor for schizophrenia—a double-blind, randomized, placebo-controlled trial
M Berk, D Copolov, O Dean, K Lu, S Jeavons, I Schapkaitz, ...
Biological psychiatry 64 (5), 361-368, 2008
6332008
Relationship between diet and mental health in children and adolescents: a systematic review
A O’neil, SE Quirk, S Housden, SL Brennan, LJ Williams, JA Pasco, ...
American journal of public health 104 (10), e31-e42, 2014
6062014
Effect of aspirin on all-cause mortality in the healthy elderly
JJ McNeil, MR Nelson, RL Woods, JE Lockery, R Wolfe, CM Reid, ...
New England Journal of Medicine 379 (16), 1519-1528, 2018
6002018
N-acetyl cysteine for depressive symptoms in bipolar disorder—a double-blind randomized placebo-controlled trial
M Berk, DL Copolov, O Dean, K Lu, S Jeavons, I Schapkaitz, ...
Biological psychiatry 64 (6), 468-475, 2008
5712008
Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways
M Maes, M Berk, L Goehler, C Song, G Anderson, P Gałecki, B Leonard
BMC medicine 10 (1), 1-19, 2012
5682012
N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action
O Dean, F Giorlando, M Berk
Journal of Psychiatry and Neuroscience 36 (2), 78-86, 2011
5402011
The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications
S Moylan, M Maes, NR Wray, M Berk
Molecular psychiatry 18 (5), 595-606, 2013
5282013
The system can't perform the operation now. Try again later.
Articles 1–20